Description |
Phillyrin is isolated from Forsythia suspensa Vahl (Oleaceae), has antibacterial and anti-inflammatory activities. Phillyrin has potential inductive effects on rat CYP1A2 and CYP2D1 activities, without affecting CYP2C11 and CYP3A1/2 activities[1].
|
Target |
CYP1A2; CYP2D1[1]
|
In Vitro |
Phillyrin (1–5 μM; pretreatment 1 hour; 24 hours) inhibits high glucose-induced FAS protein significantly in HepG2 cells[1]. Phillyrin (1–5 μM; pretreatment 1 hour; 24 hours) inhibits high glucose-induced FAS mRNA expression by suppressing SREBP-1c activation in human HepG2 hepatocytes[1]. RT-PCR[1] Cell Line: Human HepG2 hepatocyte cells Concentration: 1 μM; 2.5 μM; 5 μM Incubation Time: 24 hours Result: Reduced FAS and SREBP-1c mRNA expression.
|
Density | 1.4±0.1 g/cm3 |
Boiling Point | 730.4±60.0 °C at 760 mmHg |
Flash Point | 395.5±32.9 °C |
Exact Mass | 534.210083 |
PSA | 145.53000 |
LogP | 0.08 |
Vapour Pressure | 0.0±2.5 mmHg at 25°C |